Y-mAbs Therapeutics, Inc. - YMAB

About Gravity Analytica
Recent News
- 03.04.2025 - Fourth Quarter and Full Year 2024 Financial and Operating Results
- 03.04.2025 - Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments
- 03.04.2025 - Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments
- 03.03.2025 - Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications
- 03.03.2025 - Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications
- 02.20.2025 - Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025
- 02.20.2025 - Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025
- 02.11.2025 - Oppenheimer 35ᵗʰ Annual Life Sciences Conference
- 02.06.2025 - Y-mAbs to Present at the Oppenheimer 35ᵗʰ Annual Life Sciences Conference
- 02.06.2025 - Y-mAbs to Present at the Oppenheimer 35ᵗʰ Annual Life Sciences Conference
Recent Filings
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2025 - 4 Statement of changes in beneficial ownership of securities